What if there was a stronger pharmaceutical price competition in Spain? When regulation has a similar effect to collusion
Moreno Torres, Ivan (Generalitat de Catalunya. Autoritat Catalana de la Competència)
Xarxa de Referència en Economia Aplicada (XREAP)

Publicación:	Xarxa de Referència en Economia Aplicada (XREAP) 2011
Descripción:	74 p.
Resumen:	This paper examines statins competition in the Spanish pharmaceutical market, where prices are highly regulated, and simulates a situation in which there is unrestricted price competition. A nested logit demand model is estimated with a panel of monthly data for pharmaceuticals prescribed from 1997 to 2005. The simulation indicates that the regulation of prices is similar in its effects to cooperation among producers, since the regulated prices are close to those that would be observed in a scenario of perfect collusion. Freedom to set prices and a regulatory framework with appropriate incentives would result in a general reduction in prices and may make the current veiled competition in the form of discounts to pharmacists become more visible. The decrease in prices would be partially offset by an increase in consumption but the net effect would be an overall decrease in expenditure. The counterfactual set-up would also lead to important changes in the market shares of both manufacturers and active ingredients, and a reversal of generic drugs. Therefore, pro-competitive regulation would be welfare-enhancing but would imply winners and losers.
Derechos:	Aquest document està subjecte a una llicència d'ús de Creative Commons, amb la qual es permet copiar, distribuir i comunicar públicament l'obra sempre que se'n citin l'autor original, la universitat i la xarxa i no se'n faci cap ús comercial ni obra derivada, tal com queda estipulat en la llicència d'ús
Lengua:	Anglès
Colección:	Xarxa de Referència en Economia Aplicada (XREAP). Documents de treball de la Xarxa de Referència en Economia Aplicada (XREAP)
Colección:	XREAP ; 2011-02
Documento:	Working paper
Materia:	Pharmaceutical industry ; Statin drugs ; Competition ; Regulation ; Drugs prices ; Spain ; Preu dels medicaments ; Espanya

63 p, 478.5 KB

El registro aparece en las colecciones:
Documentos de investigación > Estudios